|
Synonyms: example 274 [WO2023133472] | IMM-6-415
Compound class:
Synthetic organic
Comment: Envometinib is the INN for a MEK inhibitor. It was included in WHO INN proposed list 133 (10th July 2025). Chemical structure match in patent WO2023133472 [1] suggests that this might be Immuneering Corporation's MEK clinical lead IMM-6-415.
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Hall BM, Decorte BL, King PJ, Leenders R, Wegert A, Fowler K, Kolitz S, Doodeman R, Poelakker J, Folmer RHA. (2023)
Mek immune oncology inhibitors and therapeutic uses thereof. Patent number: WO2023133472A1. Assignee: Immuneering Corporation. Priority date: 05/01/2023. Publication date: 13/07/2022. |